Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Gain on the Clinical Labs Business and Net Proceeds $ in Thousands |
12 Months Ended |
|---|---|
|
Jul. 31, 2023
USD ($)
| |
| Schedule Of Gain On The Clinical Labs Business And Net Proceeds Abstract | |
| Gross consideration from the sale of the Clinical Labs business | $ 113,250 |
| Closing and transaction costs | (9,941) |
| Consideration from sale of the Clinical Labs business – net | 103,309 |
| Net book value of assets sold or abandoned | (19,818) |
| Gain on sale of the Clinical Labs business before income taxes | 83,491 |
| Income tax expense | (860) |
| Gain on the sale of the Clinical Labs business after income taxes | 82,631 |
| Cash paid at closing, net of closing costs paid at closing | 106,740 |
| Proceeds due on sale of assets, cash held in escrow | (5,000) |
| Net cash proceeds from sale | $ 101,740 |
| X | ||||||||||
- Definition Amount of cash paid at closing, including adjustments. No definition available.
|
| X | ||||||||||
- Definition Amount of closing and transaction costs. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration from sale of the clinical labs business net. No definition available.
|
| X | ||||||||||
- Definition Amount of gain on sale of the clinical labs business before income taxes. No definition available.
|
| X | ||||||||||
- Definition Amount of gain on sale of the clinical labs business before income taxes. No definition available.
|
| X | ||||||||||
- Definition Amount of gross consideration from the sale of the clinical labs business. No definition available.
|
| X | ||||||||||
- Definition Amount of net book value of assets sold or abandoned. No definition available.
|
| X | ||||||||||
- Definition Amount of net cash proceeds from sale. No definition available.
|
| X | ||||||||||
- Definition Amount of proceeds due on sale of assets, cash held in escrow. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The portion of the noncash component of income tax expense for the period other than the portion from the net change in the entity's deferred tax assets and liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|